Switch to:
More From Other Websites
Roche's $8 billion InterMune buy not a signal for more big deals Sep 16 2014
BioMarin Named by CenterWatch as One of the Fastest Developers of Medicines Sep 15 2014
BioMarin to Attend Upcoming Investor Conferences in London Sep 10 2014
Merck KGaA's Kuvan Effective in Under-4 Year Olds Sep 05 2014
Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor Sep 03 2014
Early data suggest Sanofi, Regeneron drug may halve heart risk Aug 31 2014
Early data suggest Sanofi, Regeneron drug may halve heart risk Aug 31 2014
BioMarin Cuts '14 Revenue View after Voucher Sale Evaluation Aug 27 2014
Can BioMarin Pharmaceutical (BMRN) Run Higher on Strong Earnings Estimate Revisions? Aug 27 2014
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K/A, Results of Operations and Financial Condition Aug 26 2014
Roche to buy U.S. biotech firm InterMune for $8.3 billion Aug 25 2014
Roche to buy U.S. biotech firm InterMune for $8.3 bln Aug 25 2014
BioMarin to Present at Upcoming Investor Conferences Aug 19 2014
BIOMARIN PHARMACEUTICAL INC Financials Aug 08 2014
Scott Drake, CEO, and Guy A. Childs, CFO of The Spectranetics Corporation (SPNC), Interview with The... Aug 08 2014
NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales Aug 07 2014
BioMarin Weathers The Storm Aug 06 2014
4 Top Drugmakers Deliver Solid Doses Of Earnings Growth Aug 05 2014
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement Aug 01 2014
BioMarin Q2 Loss Narrower than Expected, Revenue Guidance Up Jul 31 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK